# Decreased Glucose Metabolism and Declined Chaperones Are Unique Features Required for the Survival of Senescent Fibroblasts and Pyruvate Dehydrogenase Is a Potent Senolytic Target

**Authors:** Mingzhu Zhang, Ziqi Hu, Shengwen Piao, Yingrui Song, Ying Jia, Jiaxing Liu, Ning Zhao, An Liu, Songbin Fu, Wenjing Sun, Hui Xu, Yu Yang, Steven P. Gygi, Chunshui Zhou

PMC · DOI: 10.1111/acel.70434 · Aging Cell · 2026-03-05

## TL;DR

This study identifies unique metabolic and chaperone features in senescent fibroblasts and shows that targeting pyruvate dehydrogenase can selectively kill these cells.

## Contribution

The study reveals pyruvate dehydrogenase as a novel and potent target for selectively eliminating senescent cells.

## Key findings

- Decreased glucose metabolism and reduced ATP and alpha-KG production are key features of senescent fibroblasts.
- Inhibiting pyruvate dehydrogenase or Hsp90 selectively kills senescent fibroblasts.
- Combining TCA cycle inhibition with Hsp90 inhibition enhances the elimination of senescent cells and improves physical function in aged mice.

## Abstract

Cellular senescence contributes to aging and age‐related diseases. Deep identifications of the senescence‐specific cellular features are crucial to the better understanding of the survival and maintenance of senescence and the development of novel senolytics against senescent cells. By a global proteomic profiling of senescent human BJ fibroblasts induced by ionizing radiation, 178 cellular proteins with at least 4‐fold or greater changes in abundance were identified, representing the cellular landscape of the senescent fibroblasts. Functional enrichments and biological experiments demonstrated that the decreased glucose metabolism, reduced ATP and alpha‐KG production, and declined chaperones are the most striking features associated with senescent fibroblasts. Moreover, these proteomic features are closely correlated with their transcription alterations confirmed by RT‐PCR. Respectively, inhibiting pyruvate dehydrogenase (critical enzyme to supply acetyl‐CoA to TCA cycle) or glutaminase GLS1 (crucial enzyme to supplement TCA cycle intermediate alpha‐KG) or inhibiting Hsp90 (important member of chaperones) led to the selective killing of senescent fibroblasts, indicating the essential roles of the TCA cycle or chaperones in the survival and maintenance of cellular senescence. Most importantly, co‐inhibiting the TCA cycle and Hsp90 gave rise to the enhanced selective killing of senescent fibroblasts as well as the therapy‐induced senescent cancer cells and the alleviation of physical dysfunctions in aged mice, suggesting the synergistic regulation of cellular senescence by the TCA cycle and chaperones. Thus, our profiling revealed key cellular features for the survival and maintenance in senescent normal cells, demonstrating that pyruvate dehydrogenase is a novel and potent senolytic target for the selective elimination of senescence.

By a global proteomic profiling of senescent human BJ fibroblasts induced by ionizing radiation, key cellular features required for the survival of senescent fibroblasts were revealed, and pyruvate dehydrogenase was demonstrated as a potent senolytic target for selectively eliminating senescent normal cells, particularly the therapy‐induced senescent tumor cells.

## Linked entities

- **Proteins:** GLS (glutaminase), HSP90AA1 (heat shock protein 90 alpha family class A member 1)
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, Erbb2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 13866] {aka Erbb-2, HER-2, HER2, Neu, c-erbB2, c-neu}, PFKP (phosphofructokinase, platelet) [NCBI Gene 5214] {aka ATP-PFK, PFK-C, PFK-P, PFKF}, Serpinb2 (serine (or cysteine) peptidase inhibitor, clade B, member 2) [NCBI Gene 18788] {aka PAI-2, Planh2, ovalbumin}, Pzp2 (PZP alpha-2-macroglobulin like 2) [NCBI Gene 11287] {aka A1m, A2m, MAM, Pzp}, Ercc5 (excision repair cross-complementing rodent repair deficiency, complementation group 5) [NCBI Gene 22592] {aka Xpg}, CDC37 (cell division cycle 37, HSP90 cochaperone) [NCBI Gene 11140] {aka P50CDC37}, Hk2 (hexokinase 2) [NCBI Gene 15277] {aka HKII}, PDHB (pyruvate dehydrogenase E1 subunit beta) [NCBI Gene 5162] {aka E1beta, PDHBD, PDHE1-B, PDHE1B, PHE1B}, Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}, Xrcc5 (X-ray repair complementing 5) [NCBI Gene 22596] {aka CTC85, CTCBF, Ku80, Ku86, Kup80}, HSP90B1 (heat shock protein 90 beta family member 1) [NCBI Gene 7184] {aka ECGP, GP96, GRP94, HEL-S-125m, HEL35, TRA1}, DLD (dihydrolipoamide dehydrogenase) [NCBI Gene 1738] {aka DLDD, DLDH, E3, GCSL, LAD, OGDC-E3}, ACOT7 (acyl-CoA thioesterase 7) [NCBI Gene 11332] {aka ACH1, ACT, BACH, CTE-II, LACH, LACH1}, GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}, ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216] {aka ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e}, Hsp86-ps2 (heat shock protein 86, pseudogene 2) [NCBI Gene 111042] {aka 86kDa, Hsp86-3, Hsp90}, Hsf1 (heat shock factor 1) [NCBI Gene 15499] {aka HSTF, HSTF 1, Hsf1alpha, Hsf1beta}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, LMNB1 (lamin B1) [NCBI Gene 4001] {aka ADLD, LMN, LMN2, LMNB, MCPH26}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Serpinb6a (serine (or cysteine) peptidase inhibitor, clade B, member 6a) [NCBI Gene 20719] {aka 4930482L21Rik, D330015H01Rik, PI-6, Serpinb6, Spi3, ovalbumin}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}, Stc1 (stanniocalcin 1) [NCBI Gene 20855] {aka Stc}, HSP90AA1 (heat shock protein 90 alpha family class A member 1) [NCBI Gene 3320] {aka EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N}, HSPA5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 3309] {aka BIP, GRP78, HEL-S-89n}, GLS (glutaminase) [NCBI Gene 2744] {aka AAD20, CASGID, DEE71, EIEE71, GAC, GAM}, GAA (alpha glucosidase) [NCBI Gene 2548] {aka IOPD, LOPD, LYAG}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, PDP1 (pyruvate dehydrogenase phosphatase catalytic subunit 1) [NCBI Gene 54704] {aka PDH, PDP, PDPC, PDPC 1, PPM2A, PPM2C}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1) [NCBI Gene 5160] {aka E1alpha, PDHA, PDHAD, PDHCE1A, PHE1A}, MARVELD2 (MARVEL domain containing 2) [NCBI Gene 153562] {aka DFNB49, MARVD2, MRVLDC2, Tric}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, CCT2 (chaperonin containing TCP1 subunit 2) [NCBI Gene 10576] {aka 99D8.1, CCT-beta, CCTB, HEL-S-100n, PRO1633, TCP-1-beta}, Lmnb1 (lamin B1) [NCBI Gene 16906], Hspb8 (heat shock protein family B (small) member 8) [NCBI Gene 80888] {aka Cryac, D5Ucla4, E2IG1, H11, H11K, HSP20-like}, Prkdc (protein kinase, DNA activated, catalytic polypeptide) [NCBI Gene 19090] {aka DNA-PKcs, DNAPDcs, DNAPK, DNPK1, DOXNPH, HYRC1}, Gdf15 (growth differentiation factor 15) [NCBI Gene 23886] {aka MIC-1, NAG-1, SBF}, Hspa1b (heat shock protein family A (Hsp70) member 1B) [NCBI Gene 15511] {aka HSP70B1, Hsp70, Hsp70-1, Hsp70.1, hsp68}, Serpinh1 (serine (or cysteine) peptidase inhibitor, clade H, member 1) [NCBI Gene 12406] {aka BERF-1, Cbp1, Cbp2, Hsp47, J6, Serpinh2}, CCT4 (chaperonin containing TCP1 subunit 4) [NCBI Gene 10575] {aka CCT-DELTA, Cctd, SRB}, Igfbp7 (insulin-like growth factor binding protein 7) [NCBI Gene 29817] {aka AGM, Fstl2, Mac25}, SI (sucrase-isomaltase) [NCBI Gene 6476], HSPA8 (heat shock protein family A (Hsp70) member 8) [NCBI Gene 3312] {aka HEL-33, HEL-S-72p, HSC54, HSC70, HSC71, HSP71}, CCT7 (chaperonin containing TCP1 subunit 7) [NCBI Gene 10574] {aka CCTETA, CCTH, NIP7-1, TCP1ETA}, Il25 (interleukin 25) [NCBI Gene 140806] {aka IL-17e, IL-25, Il17e}, Braf (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 109880] {aka 9930012E13Rik, B-raf, Braf-2, Braf2, C230098H17, D6Ertd631e}, ETFB (electron transfer flavoprotein subunit beta) [NCBI Gene 2109] {aka FP585, MADD}, PKM (pyruvate kinase M1/2) [NCBI Gene 5315] {aka CTHBP, HEL-S-30, OIP3, PK3, PKM2, TCB}, ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit) [NCBI Gene 2067] {aka COFS4, RAD10, UV20}, TCP1 (t-complex 1) [NCBI Gene 6950] {aka CCT-alpha, CCT1, CCTa, D6S230E, IDDPMGS, TCP-1-alpha}, HSP90AA2P (heat shock protein 90 alpha family class A member 2, pseudogene) [NCBI Gene 3324] {aka HSP90AA2, HSP90ALPHA, HSPCA, HSPCAL3}, A2m (alpha-2-macroglobulin) [NCBI Gene 232345] {aka A2mp}, CCT8 (chaperonin containing TCP1 subunit 8) [NCBI Gene 10694] {aka C21orf112, Cctq, D21S246, PRED71}, HSP90AB1 (heat shock protein 90 alpha family class B member 1) [NCBI Gene 3326] {aka D6S182, HSP84, HSP90B, HSPC2, HSPCB}, Igfbp5 (insulin-like growth factor binding protein 5) [NCBI Gene 16011] {aka IGFBP-5, IGFBP-5P}, HSPA4 (heat shock protein family A (Hsp70) member 4) [NCBI Gene 3308] {aka APG-2, HEL-S-5a, HS24/P52, HSPH2, RY, hsp70}, HSPA9 (heat shock protein family A (Hsp70) member 9) [NCBI Gene 3313] {aka CRP40, CSA, EVPLS, GRP-75, GRP75, HEL-S-124m}
- **Diseases:** TIS (MESH:D016609), Cytotoxicity (MESH:D064420), lymphomas (MESH:D008223), Alzheimer's disease (MESH:D000544), lung carcinoma (MESH:D008175), Tumor (MESH:D009369), pulmonary edema (MESH:D011654), neurodegenerative diseases (MESH:D019636), pancreatic ductal adenocarcinoma (MESH:D021441), inflammatory (MESH:D007249), osteosarcoma (MESH:D012516), cervical carcinoma (MESH:D002583), Parkinson's disease (MESH:D010300), pancreatic adenocarcinoma (MESH:D010190), AML (MESH:D015470), organ dysfunctions (MESH:D009102), lung adenocarcinoma (MESH:D000077192)
- **Chemicals:** dasatinib (MESH:D000069439), amino acids (MESH:D000596), TCA (MESH:D014238), Fatty Acid (MESH:D005227), arginine (MESH:D001120), X-Gal (MESH:C044888), superoxide (MESH:D013481), Alpha-KG (-), Dox (MESH:D004317), alpha-KG (MESH:D007656), SA (MESH:D000077145), penicillin (MESH:D010406), lysine (MESH:D008239), gemcitabine (MESH:D000093542), Tween-80 (MESH:D011136), PBS (MESH:D007854), NAD+ (MESH:D009243), tryptophan (MESH:D014364), Cobalt 60 (MESH:C000615395), acetaldehydes (MESH:D000079), Glucose (MESH:D005947), DMSO (MESH:D004121), ATP (MESH:D000255), CO2 (MESH:D002245), Gln (MESH:D005973), paraformaldehyde (MESH:C003043), agarose (MESH:D012685), lactate (MESH:D019344), quercetin (MESH:D011794), 2-DG (MESH:D003847), citrates (MESH:D002951), streptomycin (MESH:D013307), Tricarboxylic acid (MESH:D014233), pentose phosphate (MESH:D010428), Met (MESH:D008715), pyruvate (MESH:D019289), paraffin (MESH:D010232), CPI-613 (MESH:C568850), glucoside (MESH:D005960), oxygen (MESH:D010100), PEG400 (MESH:C000595213), retinaldehydes (MESH:D012172), Asn (MESH:D001216), CTX (MESH:D003520), D-galactose (MESH:D005690), aldehydes (MESH:D000447), CCK8 (MESH:D012844), 17-AAG (MESH:C112765), nicotinamide (MESH:D009536), glycogen (MESH:D006003), acetyl-CoA (MESH:D000105), IR (MESH:D007495), TRIzol (MESH:C411644)
- **Species:** Homo sapiens (human, species) [taxon 9606], Drosophila melanogaster (fruit fly, species) [taxon 7227], Mus musculus (house mouse, species) [taxon 10090], C. elegans [taxon 328850], Mycoplasma (genus) [taxon 2093]
- **Mutations:** K114558P, C for 8-12, E1218A
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), IMR-90 — Homo sapiens (Human), Finite cell line (CVCL_0347), WI-38 — Homo sapiens (Human), Finite cell line (CVCL_0579), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), -CCL- — Mus musculus (Mouse), Undefined cell line type (CVCL_M023), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), BJ — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_6573), U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12962871/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962871/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12962871/full.md

---
Source: https://tomesphere.com/paper/PMC12962871